{"id":3055,"date":"2016-05-27T16:23:19","date_gmt":"2016-05-27T16:23:19","guid":{"rendered":"http:\/\/www.medicalmarijuanainc.com\/?p=7578"},"modified":"2016-05-27T16:23:19","modified_gmt":"2016-05-27T16:23:19","slug":"medical-marijuana-inc-ceo-to-speak-on-companys-leading-role-in-burgeoning-hemp-market-at-13th-international-conference-of-the-european-industrial-hemp-association","status":"publish","type":"post","link":"https:\/\/medicalmarijuanainc.com\/2016\/05\/27\/medical-marijuana-inc-ceo-to-speak-on-companys-leading-role-in-burgeoning-hemp-market-at-13th-international-conference-of-the-european-industrial-hemp-association\/","title":{"rendered":"Medical Marijuana, Inc. CEO to Speak on Company's Leading Role in Burgeoning Hemp Market at 13th International Conference of the European Industrial Hemp Association"},"content":{"rendered":"

Market Study Set for Release at Conference Pegs Euro Market Potential for Cannabidiol (CBD)<\/a> at <\/span><\/i>\u20ac2 Billion<\/span><\/i><\/h3>\n

SAN DIEGO, CA \u2013 May 25, 2016 \u2013 <\/b>Medical Marijuana, Inc. (OTC: MJNA) today announced that at the 13<\/span>th<\/span> Annual Conference of the European Industrial Hemp<\/a> Association (EIHA) — where two major market studies are set to be released showing an expected double digit market growth and a <\/span>\u20ac2 billion<\/span> market potential in Europe for Cannabidiol (CBD) — Medical Marijuana, Inc. CEO Stuart Titus will speak on how the Company is innovating to take advantage of the burgeoning hemp market. HempMeds, a subsidiary of Medical Marijuana, Inc., will also be exhibiting at the Conference.<\/span><\/p>\n

Taking place on June 1-2 at the Rheinforum Kolner in Wesseling, Germany, near Cologne, EIHA is expected to bring in at least 250 industry professionals from more than 40 countries to learn about the latest developments concerning industrial hemp and other natural fibers, as well as hemp oil<\/a>, proteins and pharmaceuticals.<\/span><\/p>\n

\u201cThis is an exciting, yet critical time for the hemp industry,\u201d said Dr. Titus. \u201cI\u2019m thrilled with the opportunity to speak to fellow industry professionals and decision makers from across the globe about how we can work together to increase public and governmental awareness of hemp industry benefits to ensure an expanding market.\u201d<\/span><\/p>\n

According to the \u201cMarket Study on Hemp Food\u201d and the \u201cMarket Study on Cannabidiol (CBD),\u201d a double digit growth rate is expected within the fast-growing hemp food market and the potential for CBD in Europe is estimated at <\/span>\u20ac2 billion if used as a medicine for chronic diseases and a minimum of \u20ac24 million if used as over-the-counter medicine. In 2015, industrial hemp grew in the European Union to a cultivation area of 25,000 ha from 8,000 ha in 2011.<\/span><\/p>\n

\u201cEurope has always been a global hub for the rapidly growing hemp industry,\u201d Dr. Titus added. \u201cIn fact, all of Medical Marijuana Inc.\u2019s natural, botanical hemp sourced for our CBD hemp oil products such as <\/span>Real Scientific Hemp Oil<\/span>\u2122<\/span><\/a> (<\/span>RSHO<\/span>\u2122<\/span><\/a>) comes from generational European farmers. CBD can benefit the European Union and the world in many ways, from the health and wellness of its people to enormous economic opportunities.\u201d<\/span><\/p>\n

Currently, Medical Marijuana, Inc.\u2019s <\/span>RSHO<\/span>\u2122<\/span><\/a> products are shipping to more than 40 countries, including Puerto Rico, Brazil<\/a> and Mexico<\/a> for medical indications ranging from epilepsy to chronic pain (including migraines).<\/span><\/p>\n

Dr. Titus will present, \u201cThe European Union and Medical Marijuana, Inc.: A Natural Partnership\u201d on Thursday, June 2, at 5:20 p.m. Key topics covered will include:<\/span>
\n<\/span><\/p>\n